Beale P et al. Adjuvant chemotherapy (ACT) for early colon cancer (ECC): What do investigators think makes it worthwhile? Proc ASCO 2004;Abstract 6112.

Beaver K et al. Exploring the decision-making preferences of people with colorectal cancer. Health Expect 2005;8(2):103-13. Abstract

Benson AB III et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for Stage II colon cancer. J Clin Oncol 2004;22(16):3408-19. Abstract

Coates AS, Simes RJ. Patient assessment of adjuvant treatment in operable breast cancer. In: Williams CJ, editor. Introducing new treatments for cancer: Practical, ethical and legal problems. London (UK): Wiley;1992;447– 58.

Grothey A, Sargent DJ. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer. J Clin Oncol 2005;23(15):3311-3. Abstract

Love NH et al. Patient perspectives on trade-offs of adjuvant systemic therapy for stage II and III colon cancer: A survey of 150 people with colorectal cancer. Poster. ASCO GI Cancer Symposium 2006;Abstract 373.

Love NH et al. Perspectives of patients with colorectal cancer (PCRC): A pilot project to determine interests in and understanding of patient education on clinical research. Proc ASCO 2005;Abstract 3635.

Love NH et al. A “report card” on medical oncologists and oncology nurses: Survey of patients with metastatic breast cancer and companion surveys of medical oncologists and oncology nurses. San Antonio Breast Cancer Symposium 2004;Abstract 3069.

National Institute of Health (NIH). Adjuvant Therapy for Breast Cancer. NIH Consensus Statement Online 2000;17(4):1-23. Abstract

National Institute of Health (NIH). Treatment of Early-Stage Breast Cancer. NIH Consensus Statement Online 1990;8(6):1-19. Abstract

Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: How much benefit is needed? J Natl Cancer Inst Monogr 2001;30:146-52. Abstract

Solomon MJ et al. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer. Dis Colon Rectum 2003;46(10)1351-7. Abstract

Sonpavde G. Communicating the value of adjuvant chemotherapy. J Clin Oncol 2003;21(5):948-9. Abstract